Skip to main content
Clinical Trials/NCT04297852
NCT04297852UnknownNot Applicable

The Function of Nutrition Rich Vegan Drink on Inflammatory Bowel Disease

Per Bendix Jeppesen2 sites in 1 country50 target enrollmentStarted: March 3, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
50
Locations
2
Primary Endpoint
Inflammatory factors

Study Overview

Brief Summary

The aim of this project, would be to develop a new formula, with high nutrition content on a vegan basis. The investigators expect to produce this novel vegan-based juice product, which does not exist on the marked today. The juice would consist of different selected varieties of vegetables and fruits. Beside the vegetables, the juice will also contain plant oils to increase the calorie level, as well as a protein sources containing amino acids with high anabolic effects.

The products will be tested in an intervention study on patients with inflammatory bowel disease.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Between 18 and 85 years old
  • Diagnosed with or show signs of UC or Crohns disease
  • Mild symptoms i.e intestinal symptoms
  • Has had the same medicin the previous week before starting in the study

Exclusion Criteria

  • Food or vegetable allergi
  • Cognitive diseases e.g alzheimers or dementia
  • Has diabetes requiring insulin or GLP-1 analog treatment (NB: No does include T2D patients, taking tablets or other diabetes therapy)

Outcomes

Primary Outcomes

Inflammatory factors

Time Frame: 3 weeks

F-calprotectin

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Per Bendix Jeppesen
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Per Bendix Jeppesen

Associate. Prof, PhD.

University of Aarhus

Study Sites (2)

Loading locations...

Similar Trials